CAMP4 Therapeutics Corp
CAMP1.640USD
-0.010-0.61%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
1.640USD+1.640After-hours (ET)
33.06MMarket Cap
LossP/E TTM
CAMP4 Therapeutics Corp
1.640
-0.010-0.61%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2023Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---14.29M
---11.29M
-47.89%-9.69M
---6.55M
Net income from continuing operations
---12.43M
---13.28M
-15.30%-13.48M
---11.70M
Operating gains losses
--421.00K
--418.00K
-2.79%418.00K
--430.00K
Other non-cash items
--586.00K
--479.00K
16.13%468.00K
--403.00K
Change in working capital
---3.72M
--297.00K
-63.41%1.31M
--3.59M
-Change in prepaid expenses
---7.00K
---368.00K
-76.83%203.00K
--876.00K
-Change in other current liabilities
---385.00K
--385.00K
----
----
Cash from non-recurring investing activities
Cash from operating activities
---14.29M
---11.29M
-47.89%-9.69M
---6.55M
Investing cash flow
Net cash from continuing investing activities
--279.00K
--263.00K
-100.00%0.00
--207.00K
Capital expenditures
--279.00K
--263.00K
-100.00%0.00
--207.00K
Net cash flow from disposal of fixed assets
--279.00K
--263.00K
-100.00%0.00
--207.00K
Net cash flow from other investing activities
----
--0.00
----
----
Cash from non-current investing activities
Net cash flow from investing activities
---279.00K
---263.00K
100.00%0.00
---207.00K
Financing cash flow
Cash flow from continuous financing activities
---151.00K
--73.06M
-90.15%-386.00K
---203.00K
Net cash flow from debt Issuance/repayment
---36.00K
---96.00K
-1.12%-90.00K
---89.00K
Net cash flow from common stock issuance/repurchase
--0.00
--76.32M
3000.00%31.00K
--1.00K
Proceeds from stock option exercised by employees
----
--113.00K
----
----
Net cash flow from other financing activities
---115.00K
---3.27M
-184.35%-327.00K
---115.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
---151.00K
--73.06M
-90.15%-386.00K
---203.00K
Net cash flow
Beginning cash balance
--65.66M
--4.15M
-75.90%14.23M
--59.06M
Current period cash flow changes
---14.72M
--61.51M
-44.73%-10.08M
---6.96M
Ending cash balance
--50.95M
--65.66M
-92.03%4.15M
--52.09M
Free cash flow
---14.56M
---11.55M
-43.37%-9.69M
---6.76M
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
